Malnar et al., 2014 - Google Patents
Bidirectional links between Alzheimer's disease and Niemann–Pick type C diseaseMalnar et al., 2014
View PDF- Document ID
- 16981907286091779598
- Author
- Malnar M
- Hecimovic S
- Mattsson N
- Zetterberg H
- Publication year
- Publication venue
- Neurobiology of disease
External Links
Snippet
Alzheimer's disease (AD) and Niemann–Pick type C (NPC) disease are progressive neurodegenerative diseases with very different epidemiology and etiology. AD is a common cause of dementia with a complex polyfactorial etiology, including both genetic and …
- 206010001897 Alzheimer's disease 0 title abstract description 187
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Malnar et al. | Bidirectional links between Alzheimer's disease and Niemann–Pick type C disease | |
Hampel et al. | The amyloid-β pathway in Alzheimer’s disease | |
Zheng et al. | Alzheimer’s disease: insights into pathology, molecular mechanisms, and therapy | |
Karasinska et al. | Cholesterol metabolism in Huntington disease | |
Xue-Shan et al. | Imbalanced cholesterol metabolism in Alzheimer's disease | |
Jiang et al. | Trafficking regulation of proteins in Alzheimer’s disease | |
Krstic et al. | Deciphering the mechanism underlying late-onset Alzheimer disease | |
Kocherhans et al. | Reduced Reelin expression accelerates amyloid-β plaque formation and tau pathology in transgenic Alzheimer's disease mice | |
Banerjee et al. | Autophagy in neurodegenerative disorders: pathogenic roles and therapeutic implications | |
Stephan et al. | The neuropathological profile of mild cognitive impairment (MCI): a systematic review | |
Maki et al. | Phosphodiesterase III inhibitor promotes drainage of cerebrovascular β‐amyloid | |
Higuchi et al. | Mechanistic involvement of the calpain‐calpastatin system in Alzheimer neuropathology | |
Gouras et al. | Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease | |
Musiek et al. | Origins of Alzheimer's disease: reconciling cerebrospinal fluid biomarker and neuropathology data regarding the temporal sequence of amyloid-beta and tau involvement | |
Yu et al. | The role of reelin signaling in Alzheimer’s disease | |
Paulson et al. | Genetics of dementia | |
Guix | The interplay between aging‐associated loss of protein homeostasis and extracellular vesicles in neurodegeneration | |
Zhang et al. | Targeting autophagy in Alzheimer’s disease: Animal models and mechanisms | |
Kumar et al. | Role of the caspase-8/RIPK3 axis in Alzheimer’s disease pathogenesis and Aβ-induced NLRP3 inflammasome activation | |
Pahnke et al. | Cerebral ABC transporter-common mechanisms may modulate neurodegenerative diseases and depression in elderly subjects | |
Mendel et al. | The development of cerebral amyloid angiopathy in cerebral vessels. A review with illustrations based upon own investigated post mortem cases | |
Yang et al. | Alzheimer’s disease and epilepsy: An increasingly recognized comorbidity | |
Kresojević et al. | Mutations in Niemann Pick type C gene are risk factor for Alzheimer’s disease | |
Sarkar et al. | Correlation between cognitive impairment and peripheral biomarkers-significance of phosphorylated tau and amyloid-β in Alzheimer’s disease: a new insight | |
Kamble et al. | Etiology, pathogenesis of Alzheimer's disease and amyloid beta hypothesis |